Difficulty: Medium
Average Score: 89%
Practice
Ten hours following thrombolysis for an ST elevation myocardial infarction (STEMI), a client is receiving a lidocaine infusion for isolated runs of ventricular tachycardia (VT). Which finding should the nurse document in the electronic medical record as a therapeutic response to the lidocaine infusion?
Correct answer
D
Rationale
In this scenario, the correct answer is D) Decreased frequency of episodes of VT. Lidocaine is a class Ib antiarrhythmic medication that works by stabilizing the neuronal membrane and decreasing automaticity in the ventricles. It is commonly used to treat ventricular arrhythmias like ventricular tachycardia (VT). Therefore, a therapeutic response to lidocaine would be a reduction in the frequency or cessation of VT episodes, indicating that the medication is effectively managing the arrhythmia.
Option A) Stabilization of blood pressure ranges may not be directly related to the therapeutic response of lidocaine for VT. Lidocaine primarily targets cardiac arrhythmias, and its impact on blood pressure may be secondary or indirect.
Option B) Cessation of chest pain is not a typical response to lidocaine infusion for VT. While chest pain may be associated with myocardial infarction, lidocaine's primary action is on cardiac arrhythmias, not pain relief.
Option C) Reducing heart rate is not the primary goal of using lidocaine for VT. The focus is on restoring normal cardiac rhythm and preventing life-threatening arrhythmias, rather than specifically targeting heart rate reduction.
In an educational context, understanding the mechanism of action and therapeutic indications of antiarrhythmic medications like lidocaine is crucial for nurses caring for patients with cardiovascular conditions. By grasping the specific responses expected from these medications, nurses can effectively monitor and evaluate the effectiveness of treatment interventions, ensuring optimal patient outcomes.
Option A) Stabilization of blood pressure ranges may not be directly related to the therapeutic response of lidocaine for VT. Lidocaine primarily targets cardiac arrhythmias, and its impact on blood pressure may be secondary or indirect.
Option B) Cessation of chest pain is not a typical response to lidocaine infusion for VT. While chest pain may be associated with myocardial infarction, lidocaine's primary action is on cardiac arrhythmias, not pain relief.
Option C) Reducing heart rate is not the primary goal of using lidocaine for VT. The focus is on restoring normal cardiac rhythm and preventing life-threatening arrhythmias, rather than specifically targeting heart rate reduction.
In an educational context, understanding the mechanism of action and therapeutic indications of antiarrhythmic medications like lidocaine is crucial for nurses caring for patients with cardiovascular conditions. By grasping the specific responses expected from these medications, nurses can effectively monitor and evaluate the effectiveness of treatment interventions, ensuring optimal patient outcomes.